Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
35)6)44-31-30(41)29(40)28(39)23(19-37)43-31/h10
resulting in decreased lactic acid in the tumor microenvironment
Sunitinib (80 mg/kg/day) for 21 days leads to complete tumor regression in six of eight mice
from partial suppression at lower doses to full suppression at higher doses
c-Kit-IN-3 Size:Contact [email protected] for quotation 35)6)44-31-30(41)29(40)28(39)23(19-37)43-31/h10c Kit IN 3 (Compound 18) is a potent and selective c KIT kinase inhibitor with an IC50 of 4 nM. c Kit IN 3 displays great potencies against c KIT kinase and a broad spectrum of drug resistant mutants in the biochemical assay. c Kit IN 3 has improved bioavailability. c Kit IN 3 (Compound 18; 0. 1 10 M; 6 days; primary GIST patient cells) exhibits dose dependent antiproliferative effects. c Kit IN 3 (Compound 18; 0. 01 1 M; 24 hours; GIST T1, GIST T1
US$ 295.00
US$ 79.99
US$ 99.00
US$ 134.00
US$ 18.95
US$ 99.00
US$ 88.00
US$ 99.00
US$ 109.00
US$ 99.00
US$ 53.95